# FDA Warning Letter: Namita A. Goyal, M.D.
> 2024-10-22 · Center for Biologics Evaluation and Research (CBER) · `e2fdad054bcc7286`
## Letter
- **Company:** Namita A. Goyal, M.D.
- **Posted Date:** 2024-10-22
- **Letter Issue Date:** 2024-10-10
- **Issuing Office:** Center for Biologics Evaluation and Research (CBER)
## Subject
Clinical Investigator
---
*Source: [FDA Warning Letters](https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/compliance-actions-and-activities/warning-letters) · AI Analytics · CC0 1.0*